EUVIMEDEUVIMED entdecken
Crossref

Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea

Jin-Sung Yuk, Jae Yong Park, Ha Eun Sim, Je Hyung Hwang iD

Ophthalmic and Physiological Optics · 2023-03 · 43 (2) · 254-262

DOI: 10.1111/opo.13089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 06.01.2023. Verfasst von Jin-Sung Yuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Progestins, Cataract. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Postmenopausal women have a higher prevalence of cataracts than men of a similar age. This study aimed to evaluate the effects of menopausal hormone therapy (MHT) on lens opacities in postmenopausal women.

Methods

This retrospective cohort study analysed population‐based health insurance data in South Korea collected from 2002 to 2019. To determine the risk factors associated with cataract, postmenopausal women ( N = 2,506,271) were grouped according to post‐MHT use. The treatment group was further divided into the following subgroups: tibolone, combined oestrogen plus progestin by manufacturer, oral oestrogen, combined oestrogen plus progestin by physician and topical oestrogen groups. The main outcome measure was the prevalence of cataracts.

Results

The control group comprised 463,151 postmenopausal women who had never used MHT after menopause, while the treatment group included 228,033 postmenopausal women who had used MHT continuously for at least 6 months. The treatment group had a higher incidence of cataracts than the control group based on Cox proportional hazards ratio analysis. Low socioeconomic status and high parity were identified as risk factors for cataracts, and reduced risk of cataracts was associated with living in rural areas and drinking alcohol.

Conclusions

Women undergoing post‐MHT, including tibolone, had a higher incidence of cataracts. Cataract development should be a concern when examining postmenopausal patients using MHT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProgestinsCataractFemaleHumansPostmenopauseRetrospective StudiesMenopauseEstrogens

Stichwörter der Autor:innen

cataractsmenopauseoestrogenpostmenopausal hormone therapytibolone

Substanzen

ProgestinsEstrogens

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea.
  • Department of Ophthalmology, Aerospace Medical Center, Republic of Korea Air Force, Cheongju, South Korea.
  • Department of Ophthalmology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea.

ORCID-Profile: Je Hyung Hwang

Zitieren

APA

Yuk, J. S., Park, J. Y., Sim, H. E., & Hwang, J. H. (2023). Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea. Ophthalmic and Physiological Optics, 43(2), 254-262. https://doi.org/10.1111/opo.13089

Vancouver

Yuk JS, Park JY, Sim HE, Hwang JH. Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea. Ophthalmic and Physiological Optics. 2023;43(2):254-262. doi:10.1111/opo.13089

BibTeX
@article{Yuk2023,
  author = {Yuk, Jin-Sung and Park, Jae Yong and Sim, Ha Eun and Hwang, Je Hyung},
  title = {Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea},
  journal = {Ophthalmic and Physiological Optics},
  year = {2023},
  volume = {43},
  number = {2},
  pages = {254--262},
  doi = {10.1111/opo.13089}
}
Kostenlos starten →